a public good project by the
Synthesis
Company
of California

© 2026

Do‐Hyun Nam | doi.page

0 works0 citations0 h-index

Do‐Hyun Nam

Samsung Medical Center(KR)Sungkyunkwan University(KR)

Publications by Year

Research Areas

Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Meningioma and schwannoma management, Pituitary Gland Disorders and Treatments, Lung Cancer Treatments and Mutations

Most-Cited Works

→ Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial(2014)1,009 cited
→ Development of a T₁ Contrast Agent for Magnetic Resonance Imaging Using MnO Nanoparticles(2007)602 cited
→ Clinical practice guidelines for the management of adult diffuse gliomas(2020)462 cited
→ Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment(2018)411 cited
→ Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors(2018)315 cited
→ Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy(2018)210 cited

→ Application of single-cell RNA sequencing in optimizing a combinatorial therapeutic strategy in metastatic renal cell carcinoma(2016)204 cited

→ Leptomeningeal Carcinomatosis in Non–Small-Cell Lung Cancer Patients: Impact on Survival and Correlated Prognostic Factors(2013)194 cited

→ Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient(2020)194 cited

→ Diagnostic Dilemma of Pseudoprogression in the Treatment of Newly Diagnosed Glioblastomas: The Role of Assessing Relative Cerebral Blood Flow Volume and Oxygen-6-Methylguanine-DNA Methyltransferase Promoter Methylation Status(2011)193 cited